Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKropz Plc Regulatory News (KRPZ)

Share Price Information for Kropz Plc (KRPZ)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £20.59m
KRPZ Live PriceLast checked at - London Stock Exchange

Intraday Kropz Plc Share Chart

Equity Facility Draw Down

7 Mar 2022 07:00

RNS Number : 7475D
Kropz PLC
07 March 2022
 

7 March 2022

Kropz Plc

("Kropz" or the "Company")

 

Equity Facility Draw Down

 

Kropz Plc (AIM: KRPZ), an emerging African phosphate explorer and developer, is pleased to confirm that it has made a further quarterly draw down request under one of the equity facilities with its major shareholder, the ARC Fund ("ARC"). The Company had/has three equity facilities with ARC:

- the first being for an amount of US$ 40 million (which cannot exceed ZAR 680 million), as announced on 13 May 2020 ("Original Equity Facility");

- the second for an amount of up to US$ 5 million (which cannot exceed ZAR 85 million), as announced on 26 February 2021 ("New Equity Facility"); and

- the third for a total commitment of up to ZAR 200 million to be provided by ARC, as announced on 29 September 2021 ("New ZAR Equity Facility").

 

As announced on 7 September 2021, the Original Equity Facility is fully drawn down. In accordance with the terms of the Original Equity Facility, any fees associated with the bank guarantee provided by ARC, would be settled by the issue of new ordinary shares to ARC. ARC notified the Company that the final guarantee fees due to ARC amounted to US$311,733. These fees will be settled by the issue of 3,971,712 new ordinary shares at the issue price of 6.75 pence per share to ARC on 10 March 2022.

 

In addition, the Company has made the fifth and final draw down request of US$ 200,000 under the New Equity Facility. This draw down will be settled by the issue of 3,474,536 new ordinary shares at the issue price of 4.20 pence per share to ARC on 10 March 2022. The proceeds drawn down from the New Equity Facility will be utilised for general corporate purposes.

 

To date ZAR 127 million has been drawn down on the New ZAR Equity Facility. The remaining ZAR 73 million can be drawn down by the Company, at the sole discretion of ARC.

 

Admission and Total Voting Rights

 

Application will be made for the 7,446,248 new ordinary shares to admission to trading on the AIM Market of the London Stock Exchange ("AIM"). It is expected that admission will become effective and that dealings in the new ordinary shares will commence at 8.00 a.m. on 10 March 2022 ("Admission").

 

On Admission, the Company's issued share capital will consist of 923,718,223 ordinary shares with voting rights. There are no shares held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Change in Shareholding

 

Following issue of the 7,446,248 new ordinary shares, ARC will be directly interested in 768,339,330 ordinary shares of the Company representing 83.2 per cent. of the issued share capital.

 

In addition, ARC holds call options over certain shares held by Kropz International S.a.r.l as set out in the announcement on 26 February 2021.

 

 

For further information visit www.kropz.com or contact:

 

Kropz Plc

 

Mark Summers (CEO)

+27 (0) 79 744 8708

 

 

Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

George Grainger

Ciara Donnelly

+44 (0) 20 7383 5100

 

 

Hannam & Partners

Broker

Andrew Chubb

Ernest Bell

 +44 (0) 20 7907 8500

 

 

Tavistock

Financial PR & IR (UK)

Nick Elwes

Jos Simson

Oliver Lamb

+44 (0) 207 920 3150

kropz@tavistock.co.uk

 

 

R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0) 11 880 3924

james@rasc.co.za 

 

About Kropz Plc

Kropz is an emerging African explorer and developer of plant nutrient feed minerals with phosphate projects in South Africa and the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLRVSISIIF
Date   Source Headline
29th May 20267:00 amRNSTotal Voting Rights
11th May 202610:27 amRNSDrawdown on Bridge Loan Facilities
30th Apr 202612:42 pmRNSECA Approval and Admission Date of Shares
20th Apr 20268:44 amRNSOperational Update
9th Mar 202611:49 amRNSDrawdown on Bridge Loan Facilities
25th Feb 20267:00 amRNSResults of WRAP Offer and Update on Subscription
20th Feb 20264:31 pmRNSWRAP Retail Offer for up to £91,077
20th Feb 20264:30 pmRNSFundraising, Amendment to Loan Terms & Update
26th Jan 202612:56 pmRNSDrawdown on Bridge Loan Facilities
18th Dec 20257:00 amRNSUnaudited Results for Six Months end 30 Sept 2025
17th Dec 20257:00 amRNSLegal Claim Update
9th Dec 20251:08 pmRNSDrawdown on Bridge Loan Facilities
8th Dec 20257:00 amRNSLoan Facility and Related Party Transaction
24th Nov 20257:00 amRNSTrading Update
6th Nov 20251:31 pmRNSResults of General Meeting
31st Oct 20252:41 pmRNSDrawdown on Bridge Loan Facilities
30th Sep 20255:08 pmRNSNotice of GM
29th Sep 20251:49 pmRNSResult of AGM
26th Sep 20254:16 pmRNSFinal Audited Results
4th Sep 20251:08 pmRNSNotice of AGM
27th Aug 202510:10 amRNSDrawdown on Bridge Loan Facilities
13th Aug 202511:21 amRNSDrawdown on Bridge Loan Facilities
30th Jul 20254:31 pmRNSDirector Disclosure Update
22nd Jul 20253:02 pmRNSLegal Claim Update
16th Jul 20251:08 pmRNSDrawdown on Bridge Loan Facilities
14th Jul 20255:04 pmRNSTrading Update and Loan Facility
30th May 20251:24 pmRNSDrawdown on Bridge Loan Facilities
28th May 20253:59 pmRNSFormal Execution of Loan Facility
21st May 20254:55 pmRNSTrading Update and Loan Facility
19th Mar 20257:23 amRNSNotice of Motion application by WWF SA
26th Feb 20257:00 amRNSTrading Update and Notification of Legal Claim
19th Dec 20247:00 amRNSUnaudited Results for Six Months end 30 Sept 2024
6th Nov 20242:00 pmRNSPassing of Lord Renwick of Clifton
4th Nov 20242:08 pmRNSResults of General Meeting
31st Oct 20247:00 amRNSTotal Voting Rights
17th Oct 20247:00 amRNSAdmission of Shares and Total Voting Rights
10th Oct 20244:30 pmRNSReceipt of Exchange Control Approval
30th Sep 20246:03 pmRNSFinal Audited Results
27th Sep 20241:05 pmRNSResult of AGM
20th Sep 202412:57 pmRNSResults of General Meeting
10th Sep 20247:00 amRNSResult of REX Retail Offer, Update on Subscription
3rd Sep 20247:01 amRNSRetail offer to raise up to £1.8 million
3rd Sep 20247:00 amRNSRestructuring, Fundraising, Notice of GM
27th Aug 20247:00 amRNSDrawdown on Bridge Loan Facilities
11th Jul 20247:00 amRNSTrading Update and further loan facility
20th Jun 20247:52 amRNSUpdate Mineral Resource Estimate - Elandsfontein
10th Jun 202411:05 amRNSStatement regarding share price movement
3rd Apr 20244:22 pmRNSDrawdown on Bridge Loan and BNP Loan Update
28th Mar 202412:11 pmRNSDrawdown on Bridge Loan Facilities
28th Mar 20248:22 amRNSUnaudited Results for 12 Months ended 31 Dec 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.